Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Avidity Biosciences Prices $600 Million Upsized Public Offering of Common Stock
Wilson Sonsini Goodrich & Rosati along with Latham & Walkins have advised Avidity Biosciences. Avidity Biosciences, Inc., a biopharmaceutical company listed on Nasdaq under the symbol...
LLT Management’s Trade Libel Case
King & Spalding defeated a motion to dismiss for Johnson & Johnson subsidiary LLT Management, LLC. LLT Management, LLC, a subsidiary of Johnson & Johnson, brought...
Janux Therapeutics’ $350 Million Common Stock Offering
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
Avidity Biosciences’ $300 Million Common Stock Offering
Latham & Watkins advised Avidity Biosciences on the deal, and Wilson Sonsini Goodrich & Rosati acted as patent counsel to Avidity. Avidity Biosciences, Inc. (Nasdaq: RNA),...
Avidity Biosciences’ $461 Million Common Stock Offering
Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
Boundless Bio’s $100 Million IPO
Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Boundless Bio on the offering, and Cooley advised the underwriters. Boundless Bio, Inc. (Nasdaq: BOLD) a clinical...
Matthey v. Johnson & Johnson et al.
King & Spalding secured a defense verdict for Johnson & Johnson in the cosmetic talcum powder litigation. In reaching its’ conclusion, the jury found that talc...
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Iovance Biotherapeutics’ US$211 Million Common Stock Offering
DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...